At Pittcon, AB Sciex Previews Upcoming MS Debut; Agilent Discusses Varian's Contributions to Life Sci | GenomeWeb

By Tony Fong

The annual Pittcon gathering wrapped up this week in Orlando, Fla. Below is a wrap-up of the top news in proteomics that played out at the conference.

One month after joining Danaher, AB Sciex continued trying to reestablish its leadership position in the mass-spectrometry space by saying it intends to debut a new "groundbreaking" platform later this year. The company has also penned a partnership with the University of Geneva to build out applications and workflows for the new platform.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.